Sign up to save your podcasts
Or
Share NCIMI Voices Episode 6: AI and lung health – Detecting lung nodules and beyond
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
NCIMI Voices Episode 6: AI and lung health – Detecting lung nodules and beyond
On this episode of NCIMI Voices, we celebrate advances in algorithms for detecting early stage lung cancer.
Claire Bloomfield speaks with by Prof Fergus Gleeson, NCIMI's Chief Medical Officer and chief investigator for the DART research programme.
They are joined by Optellum's CEO Václav Potěšil who talks about the company's recent FDA clearance in the US for Virtual Nodule Clinic to detect potentially cancerous nodules (small lesions) on lungs.
We cover:
- Fergus on the DART programme for lung health and how it works with Optellum as a partner.
- Václav explains how their AI algorithm supports workflow and accurate decision making in a clinical setting.
- Václav explaining why FDA clearance for Optellum’s Virtual Nodule Clinic is “The biggest milestone in the history of our company”.
- How has Covid 19 impacted diagnosis and treatment of lung cancer? How could AI help support workflow?
- Where are we heading next? Optellum’s vision for CE marking and wider lung health to enable patients to be diagnosed and doctors to make optimum decisions for treatment to radically improve patient outcomes.
About DART
About Optellum
Optellum is a lung health company, providing artificial intelligence software for clinicians to make the best decisions for early diagnosis and optimal treatment for every patient.
Optellum was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, and cured. The company’s vision is to redefine early intervention of diseases like lung cancer, by enabling every clinician, in every hospital, to make the right decisions and give their patients the best chance to fight back.
Optellum’s Virtual Nodule Clinic is the first clinical decision support software for personalised early diagnosis and treatment of lung cancer, based on artificial intelligence (AI) and machine learning applied to the world’s largest clinical dataset.
https://optellum.com
https://twitter.com/Optellum
https://www.linkedin.com/company/optellum
Thanks to our funders, Innovate UK.
Check out our BRAND NEW WEBSITE! https://ncimi.co.uk/
Follow Claire on LinkedIn
Follow us on Twitter: @NCIMImaging
View all episodes
By NCIMI VoicesOn this episode of NCIMI Voices, we celebrate advances in algorithms for detecting early stage lung cancer.
Claire Bloomfield speaks with by Prof Fergus Gleeson, NCIMI's Chief Medical Officer and chief investigator for the DART research programme.
They are joined by Optellum's CEO Václav Potěšil who talks about the company's recent FDA clearance in the US for Virtual Nodule Clinic to detect potentially cancerous nodules (small lesions) on lungs.
We cover:
- Fergus on the DART programme for lung health and how it works with Optellum as a partner.
- Václav explains how their AI algorithm supports workflow and accurate decision making in a clinical setting.
- Václav explaining why FDA clearance for Optellum’s Virtual Nodule Clinic is “The biggest milestone in the history of our company”.
- How has Covid 19 impacted diagnosis and treatment of lung cancer? How could AI help support workflow?
- Where are we heading next? Optellum’s vision for CE marking and wider lung health to enable patients to be diagnosed and doctors to make optimum decisions for treatment to radically improve patient outcomes.
About DART
About Optellum
Optellum is a lung health company, providing artificial intelligence software for clinicians to make the best decisions for early diagnosis and optimal treatment for every patient.
Optellum was founded so that every lung disease patient is diagnosed and treated at the earliest possible stage, and cured. The company’s vision is to redefine early intervention of diseases like lung cancer, by enabling every clinician, in every hospital, to make the right decisions and give their patients the best chance to fight back.
Optellum’s Virtual Nodule Clinic is the first clinical decision support software for personalised early diagnosis and treatment of lung cancer, based on artificial intelligence (AI) and machine learning applied to the world’s largest clinical dataset.
https://optellum.com
https://twitter.com/Optellum
https://www.linkedin.com/company/optellum
Thanks to our funders, Innovate UK.
Check out our BRAND NEW WEBSITE! https://ncimi.co.uk/
Follow Claire on LinkedIn
Follow us on Twitter: @NCIMImaging